Navigating the complex and diverse world of pharma from head to toe.
Our pharma expertise
Understanding the pharmaceutical industry requires more than a good grasp of human biology and different indication areas. Diverse healthcare system structures, medical affairs and regulatory frameworks, cultural differences, physician and patient profiles, ethical marketing strategies – to name just a few factors – make the pharmaceutical industry one of the most complex.
This is why we have made it our business to consolidate decades of pharma industry knowledge and research agency expertise to help our clients navigate pharmaceutical’s complexities.
Industry experts on board
International team members and trusted industry partners covering healthcare systems worldwide.
From familial hypercholesterolemia and solid tumours to OTC supplements and decongestants – there is little we have not researched.
Target group access
We work with specialist healthcare recruiters to reach general physicians, specialists, pharmacists, patients, payers, healthcare administrators, and KOLs.
Below are a few examples of studies we have done, but we would rather demonstrate our knowledge personally. Get in touch to ask us any questions you have and learn more about our expertise in your industry.
Through preliminary studies – including desk research as well as qualitative interviews with patients and HCPs – a comprehensive understanding of the indication, the views, language and needs of the breast cancer patients was generated.
The conjoint study was built upon insights from preliminary research and validated in an extensive pre-test phase before launching. Each step in the research process, analysis and data collection with a robust sample was documented and justified in detail to ensure acceptance by IQWiG's reviewers.
- Market landscape study for an orphan drug manufacturer
- Launch and competitive go-to market strategy for a new drug substitution product
- Market segmentation for an allergy medication provider
- Portfolio strategy for a new umbrella brand after a major acquisition
- Competitive strategy for an Rx product to stand out against generic competitors